Exchange Traded Concepts, LLC Deciphera Pharmaceuticals, Inc. Transaction History

Exchange Traded Concepts, LLC

  • $4.74 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024
BUY
$13.58 - $17.36 $101,333 - $129,540
7,462 Added 71.43%
17,909 $281,000
Q4 2023

Jan 05, 2024
BUY
$10.11 - $16.54 $26,781 - $43,814
2,649 Added 33.97%
10,447 $168,000
Q3 2023

Oct 18, 2023
SELL
$12.46 - $15.48 $24,982 - $31,037
-2,005 Reduced 20.45%
7,798 $99,000
Q2 2023

Jul 20, 2023
BUY
$13.28 - $15.96 $130,183 - $156,455
9,803 New
9,803 $138,000

Others Institutions Holding DCPH

# of Institutions
6
Shares Held
293K
Call Options Held
500
Put Options Held
0
View Full List

About Deciphera Pharmaceuticals, Inc.

DCPH Quotes by TradingView
  • Ticker DCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,822,100
  • Description
  • Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...
More about DCPH
Track This Portfolio

Track Exchange Traded Concepts, LLC Portfolio

Follow Exchange Traded Concepts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email